Skip to main content
Caplight Logo









VelaVigo

VelaVigo

Private
ShanghaiHealthcare & Life Scienceshttps://www.velavigo.com/

Last Round

VC Round

Jul 28, 2025

Total Funding Raised

$100M

Company Overview

VelaVigo is a biopharmaceutical company that specializes in the discovery and development of multispecific antibodies and antibody-drug conjugates for oncology and autoimmune diseases.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Non-AI

Keywords

biologic drug discovery and developmentmulti-specific antibody discovery platformantibody-drug conjugate (ADC) development platformpreclinical drug candidate out-licensingfirst-in-class (FIC) biologic drug candidatesoncology and autoimmune disease therapeuticsbispecific antibody developmentbiopharmaceutical asset licensingbest-in-class (BIC) drug candidatesNectin4/TROP2 bispecific ADC

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

VelaVigo Comparables

Compare VelaVigo with similar companies based on industry and business-model similarity.

VelaVigo comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
MediLink Therapeutics
90%
Duality Biotherapeutics Inc
82%
BioNTech SE
79%

VelaVigo Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJul 28, 2025
Pre SeedDec 31, 2024
AngelNov 15, 2021

Key People

Founding team and executive leadership

Tong Zhang

Co-founder, CBO CFO

Founding Team

Jing Li

Founder and CEO

Founding Team

Vilar Ye

Sr. Manager, CEO Office

Executive Team

VelaVigo Investors

Notable investors and investment history

VelaVigo investors
InvestorRounds
HighLight CapitalVC Round, Pre Seed, Angel
Legend StarVC Round, Pre Seed
Shanghai Healthcare CapitalVC Round, Pre Seed
Zoo CapitalVC Round, Pre Seed
Highlight CapitalVC Round, Pre Seed
Northern Light Venture CapitalVC Round
Delian CapitalVC Round, Pre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 5, 2025

    Monthly visitors grew 1573% MoM, from 113 to 1.9K.

  • Dec 31, 2024

    $50M round led by Shanghai Healthcare Capital and Panacea Venture Healthcare.

VelaVigo Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

VelaVigo Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about VelaVigo's valuation, stock price, and market status.

Firmographic Details

HeadquartersShanghai
Employee Range20
Year Founded2021
Last FundingJul 28, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?